What’s In The Physician’s Toolbox? Medical Management Of Obesity, Diabetes Risk And Cardiovascular Risk Factors In Psychosis.

Presentation First Author: 
Katherine Samaras - Shiers

People with psychosis have a 20-year shortfall in life expectancy, attributable to cardiovascular disease. People with psychosis also have higher diabetes rates. Mental illness, social isolation and other sociodemographic factors often impair performance in often complex diabetes self-care, with poorer control and ensuing risks of diabetes complications (amputation, renal failure and heart disease). Weight gain and/or obesity associated with antipsychotropic medication-initiation compounds all these risks. Prior to catastrophic loss of physical health, there are many opportunities for cardiometabolic intervention, namely prevention of weight gain, diabetes and cardiovascular risk. Physical health care instigated at the time of antipsychotropic- initiation offsets development of adverse cardiometabolic risk, at least in the short term. The medical interventions that can improve cardiometabolic risk will be discussed, particularly the evidence base for prevention of weight gain, cardiometabolic risk and diabetes, from studies in psychosis and other populations at high-risk of cardiac disease and diabetes. This will include a review of dietary interventions, anti-obesity and lipid–lowering medications and over-the-counter drugs. With training and support, medical practitioners from many different disciplines could be engaged in the cardiometabolic care of people with psychosis. Clinical guidelines (adopted and in development) will be discussed. Better physical health in people with psychosis can be achieved, with cohesive multidisciplinary care instigated early.

Conference Name: 
Presentation Date: 
January, 2013
Additional Authors: 
Katherine Samaras
See other presentations in this session: